Christopher Aker - May 17, 2021 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Signature
Christopher Aker
Stock symbol
RGLS
Transactions as of
May 17, 2021
Transactions value $
-$765
Form type
4
Date filed
5/17/2021, 07:12 PM
Next filing
Jan 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Sale -$765 -860 -2.02% $0.89 41.8K May 17, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person on 11/12/2018. These sales are made pursuant to an existing 10b5-1 plan under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.